Horan Capital Advisors’s Gilead Sciences GILD Stock Holding History

Horan Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,580	Closed	-$100K	–	152
2020 Q3	$100K	Buy	+1,580	New	+$110K	0.06%	115
2020 Q1	–	Sell	-1,045	Closed	-$68K	–	141
2019 Q4	$68K	Hold	1,045	–	–	0.04%	131
2019 Q3	$66K	Buy	+1,045	New	+$68.3K	0.04%	128
2019 Q2	–	Sell	-1,140	Closed	-$74K	–	137
2019 Q1	$74K	Buy	+1,140	New	+$75.8K	0.05%	120
2017 Q4	–	Sell	-1,780	Closed	-$144K	–	145
2017 Q3	$144K	Buy	+1,780	New	+$136K	0.09%	81

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Horan Capital Advisors's GILD Position: Q4 2020 in Review

Horan Capital Advisors sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 1,580 shares — an estimated $100K sold.

Horan Capital Advisors first reported a position in GILD in Q3 2017 and held it in 5 quarters. The position peaked at $144K in Q3 2017. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

Horan Capital Advisors reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
Horan Capital Advisors sold 1,580 Gilead Sciences shares in Q4 2020, an estimated $100K.
Horan Capital Advisors first reported a position in Gilead Sciences in Q3 2017 and held it in 5 quarters.
Horan Capital Advisors's Gilead Sciences position peaked at $144K in Q3 2017.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Horan Capital Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.